Halasz Jozsef, Toth Mate, Mikics Eva, Hrabovszky Erik, Barsy Boglarka, Barsvari Beata, Haller Jozsef
Department of Behavioral Neurobiology, Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest 1083, Hungary.
Biol Psychiatry. 2008 Feb 1;63(3):271-8. doi: 10.1016/j.biopsych.2007.04.022. Epub 2007 Aug 3.
Neurokinin1 (NK1) receptor blockers were recently proposed for the treatment of anxiety and depression. Disparate data suggest that NK1 receptors are also involved in the control of aggressiveness, but their role is poorly known.
We evaluated the aggression-induced activation of NK1 neurons by double-labeling brain sections for NK1 receptors and c-Fos in two laboratory models of aggression. We also studied the effects of the NK1 antagonist L-703,606 in these models.
Aggressive encounters activated a large number of NK1 receptor-expressing neurons in areas relevant for aggression control. The activation was aggression-specific, because the effects of psychosocial encounters (that allowed sensory but not physical contacts) were markedly weaker. In the medial amygdala, the activation of neurons expressing NK1 receptors showed a marked positive correlation with the occurrence of violent attacks. In resident/intruder conflicts, NK1 blockade lowered the number of hard bites, without affecting milder forms of attack. In the model of violent aggression, attacks on vulnerable body parts of opponents (the main indicators of violence in this model) were decreased to the levels seen in control subjects. Autonomic deficits seen in the model of violent aggression were also ameliorated. The effects of the compound were not secondary to changes in locomotion or in the behavior of intruders.
Our data show that neurons expressing NK1 receptors are involved in the control of aggressiveness, especially in the expression of violent attacks. This suggests that NK1 antagonists-beyond anxiety and depression-might also be useful in the treatment of aggressiveness and violence.
神经激肽1(NK1)受体阻滞剂最近被提议用于治疗焦虑和抑郁。不同的数据表明,NK1受体也参与攻击行为的控制,但其作用尚不清楚。
我们在两种攻击行为的实验室模型中,通过对脑切片进行NK1受体和c-Fos的双重标记,评估了攻击行为诱导的NK1神经元激活情况。我们还研究了NK1拮抗剂L-703,606在这些模型中的作用。
攻击性遭遇激活了与攻击行为控制相关区域中大量表达NK1受体的神经元。这种激活具有攻击特异性,因为社会心理遭遇(允许感官接触但不涉及身体接触)的影响明显较弱。在内侧杏仁核中,表达NK1受体的神经元激活与暴力攻击的发生呈显著正相关。在居主/入侵者冲突中,NK1阻断降低了狠狠撕咬的次数,而不影响较轻形式的攻击。在暴力攻击模型中,对对手易受攻击身体部位的攻击(该模型中暴力的主要指标)减少到了对照组所见的水平。暴力攻击模型中出现的自主神经功能缺陷也得到了改善。该化合物的作用并非继发于运动或入侵者行为的改变。
我们的数据表明,表达NK1受体的神经元参与攻击行为的控制,尤其是暴力攻击的表达。这表明,NK1拮抗剂除了治疗焦虑和抑郁外,可能还对攻击行为和暴力的治疗有用。